The potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmology
Introduction: Pamrevlumab, a monoclonal antibody targeting CTGF, is considered a potential therapy for eye diseases involving fibrosis. The aim of this study was to explore its potential in treating eye diseases. Methods: A systematic review was conducted following PRISMA guidelines, searc...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2025-06-01
|
| Series: | Pharmacia |
| Online Access: | https://pharmacia.pensoft.net/article/144964/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|